Sphera Funds Management Ltd. Apellis Pharmaceuticals, Inc. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 206,251 shares of APLS stock, worth $5.36 Million. This represents 1.36% of its overall portfolio holdings.
Number of Shares
206,251
Previous 215,873
4.46%
Holding current value
$5.36 Million
Previous $6.23 Million
5.72%
% of portfolio
1.36%
Previous 1.14%
Shares
6 transactions
Others Institutions Holding APLS
# of Institutions
302Shares Held
123MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$318 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$309 Million17.73% of portfolio
-
Wellington Management Group LLP Boston, MA11.8MShares$307 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$261 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$250 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.86B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...